Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

NCT05227820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: NE3107

Sponsor

Neurological Associates of West Los Angeles

Collaborators

[object Object]